Brown Brothers Harriman & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $32.2M | Buy |
127,844
+21,443
| +20% | +$4.61M | 0.14% | 106 |
|
|
2026
Q1 | $23.1M | Buy |
106,401
+7,395
| +7% | +$1.64M | 0.12% | 110 |
|
|
2025
Q4 | $22.6M | Buy |
99,006
+8,140
| +9% | +$1.85M | 0.12% | 101 |
|
|
2025
Q3 | $21M | Buy |
90,866
+3,867
| +4% | +$787K | 0.13% | 94 |
|
|
2025
Q2 | $16.1M | Buy |
86,999
+7,340
| +9% | +$1.36M | 0.1% | 99 |
|
|
2025
Q1 | $16.7M | Sell |
79,659
-26,432
| -25% | -$5.14M | 0.12% | 97 |
|
|
2024
Q4 | $18.9M | Buy |
106,091
+17,305
| +19% | +$3.18M | 0.13% | 92 |
|
|
2024
Q3 | $17.5M | Buy |
88,786
+2,182
| +3% | +$407K | 0.12% | 91 |
|
|
2024
Q2 | $14.9M | Sell |
86,604
-3,588
| -4% | -$594K | 0.11% | 96 |
|
|
2024
Q1 | $16.4M | Sell |
90,192
-957
| -1% | -$165K | 0.13% | 89 |
|
|
2023
Q4 | $14.1M | Sell |
91,149
-9,070
| -9% | -$1.32M | 0.12% | 88 |
|
|
2023
Q3 | $14.9M | Buy |
100,219
+4,787
| +5% | +$703K | 0.13% | 72 |
|
|
2023
Q2 | $12.9M | Sell |
95,432
-1,112
| -1% | -$163K | 0.1% | 75 |
|
|
2023
Q1 | $15.4M | Buy |
96,544
+1,781
| +2% | +$272K | 0.13% | 65 |
|
|
2022
Q4 | $15.3M | Buy |
94,763
+2,841
| +3% | +$436K | 0.13% | 65 |
|
|
2022
Q3 | $12.3M | Buy |
91,922
+2,695
| +3% | +$387K | 0.11% | 68 |
|
|
2022
Q2 | $13.7M | Buy |
89,227
+2,050
| +2% | +$313K | 0.12% | 69 |
|
|
2022
Q1 | $14.1M | Buy |
87,177
+5,028
| +6% | +$730K | 0.1% | 71 |
|
|
2021
Q4 | $11.1M | Buy |
82,149
+14,190
| +21% | +$1.68M | 0.06% | 88 |
|
|
2021
Q3 | $7.33M | Buy |
67,959
+1,916
| +3% | +$219K | 0.04% | 100 |
|
|
2021
Q2 | $7.44M | Sell |
66,043
-749
| -1% | -$84.4K | 0.04% | 101 |
|
|
2021
Q1 | $7.23M | Buy |
66,792
+1,749
| +3% | +$187K | 0.05% | 98 |
|
|
2020
Q4 | $6.97M | Sell |
65,043
-7,653
| -11% | -$735K | 0.05% | 94 |
|
|
2020
Q3 | $6.37M | Buy |
72,696
+3,629
| +5% | +$342K | 0.05% | 90 |
|
|
2020
Q2 | $6.78M | Buy |
69,067
+2,945
| +4% | +$259K | 0.05% | 87 |
|
|
2020
Q1 | $5.04M | Buy |
66,122
+7,784
| +13% | +$663K | 0.04% | 94 |
|
|
2019
Q4 | $5.17M | Sell |
58,338
-4,417
| -7% | -$367K | 0.03% | 112 |
|
|
2019
Q3 | $4.75M | Sell |
62,755
-3,370
| -5% | -$231K | 0.03% | 112 |
|
|
2019
Q2 | $4.81M | Sell |
66,125
-1,329
| -2% | -$104K | 0.03% | 107 |
|
|
2019
Q1 | $5.44M | Buy |
67,454
+4,405
| +7% | +$360K | 0.04% | 102 |
|
|
2018
Q4 | $5.81M | Sell |
63,049
-801
| -1% | -$70.4K | 0.04% | 97 |
|
|
2018
Q3 | $6.04M | Buy |
63,850
+6,632
| +12% | +$629K | 0.04% | 95 |
|
|
2018
Q2 | $5.3M | Sell |
57,218
-3,522
| -6% | -$344K | 0.03% | 93 |
|
|
2018
Q1 | $5.75M | Sell |
60,740
-1,907
| -3% | -$209K | 0.03% | 92 |
|
|
2017
Q4 | $6.06M | Buy |
62,647
+3,524
| +6% | +$332K | 0.03% | 89 |
|
|
2017
Q3 | $5.25M | Sell |
59,123
-980
| -2% | -$74.6K | 0.03% | 88 |
|
|
2017
Q2 | $4.36M | Sell |
60,103
-1,873
| -3% | -$126K | 0.02% | 91 |
|
|
2017
Q1 | $4.04M | Sell |
61,976
-3,767
| -6% | -$237K | 0.02% | 97 |
|
|
2016
Q4 | $4.12M | Sell |
65,743
-212
| -0.3% | -$12.9K | 0.02% | 96 |
|
|
2016
Q3 | $4.16M | Sell |
65,955
-2,272
| -3% | -$147K | 0.02% | 95 |
|
|
2016
Q2 | $4.22M | Sell |
68,227
-3,347
| -5% | -$204K | 0.02% | 100 |
|
|
2016
Q1 | $4.09M | Sell |
71,574
-1,231
| -2% | -$68.6K | 0.02% | 103 |
|
|
2015
Q4 | $4.31M | Buy |
72,805
+912
| +1% | +$52.5K | 0.02% | 102 |
|
|
2015
Q3 | $3.91M | Sell |
71,893
-1,174
| -2% | -$76.4K | 0.02% | 108 |
|
|
2015
Q2 | $4.91M | Sell |
73,067
-554
| -0.8% | -$36.2K | 0.02% | 98 |
|
|
2015
Q1 | $4.31M | Sell |
73,621
-11,268
| -13% | -$681K | 0.02% | 106 |
|
|
2014
Q4 | $5.55M | Sell |
84,889
-1,215
| -1% | -$76.6K | 0.02% | 103 |
|
|
2014
Q3 | $4.97M | Sell |
86,104
-4,381
| -5% | -$243K | 0.02% | 109 |
|
|
2014
Q2 | $5.11M | Sell |
90,485
-10,676
| -11% | -$560K | 0.02% | 112 |
|
|
2014
Q1 | $5.2M | Sell |
101,161
-109,293
| -52% | -$5.52M | 0.02% | 102 |
|
|
2013
Q4 | $11.1M | Buy |
210,454
+96,967
| +85% | +$4.77M | 0.03% | 99 |
|
|
2013
Q3 | $5.08M | Sell |
113,487
-61,592
| -35% | -$2.73M | 0.02% | 102 |
|
|
2013
Q2 | $7.24M | Buy |
+175,079
| New | +$7.66M | 0.03% | 89 |
|
Other funds holding ABBV
Brown Brothers Harriman & Co's ABBV Position: Q2 2026 in Review
Brown Brothers Harriman & Co increased its AbbVie (ABBV) stake by 20% in Q2 2026, buying an estimated $4.61M and bringing the position to 127,844 shares worth $32.2M. The position accounts for 0.14% of the portfolio, ranked #106.
Brown Brothers Harriman & Co first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,206 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Brown Brothers Harriman & Co held 127,844 shares of AbbVie worth $32.2M as of Q2 2026.
- Brown Brothers Harriman & Co bought 21,443 AbbVie shares in Q2 2026, an estimated $4.61M.
- AbbVie made up 0.14% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #106 holding.
- Brown Brothers Harriman & Co first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 4,206 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.